1207113-88-9

1207113-88-9 structure
1207113-88-9 structure
  • Name: CCG-100602
  • Chemical Name: ccg-100602
  • CAS Number: 1207113-88-9
  • Molecular Formula: C21H17ClF6N2O2
  • Molecular Weight: 478.815
  • Catalog: Signaling Pathways GPCR/G Protein Ras
  • Create Date: 2018-06-22 16:48:33
  • Modify Date: 2024-03-06 06:15:22
  • CCG-100602 is a specific inhibitor of myocardin-related transcription factor A/serum response factor (MRTF-A/SRF) signaling. CCG-100602 specifically block MRTF-A nuclear localization and thus inhibit the fibrogenic transcription factor SRF[1][2].

Name ccg-100602
Synonyms 1-[3,5-Bis(trifluoromethyl)benzoyl]-N-(4-chlorophenyl)-3-piperidinecarboxamide
3-Piperidinecarboxamide, 1-[3,5-bis(trifluoromethyl)benzoyl]-N-(4-chlorophenyl)-
Description CCG-100602 is a specific inhibitor of myocardin-related transcription factor A/serum response factor (MRTF-A/SRF) signaling. CCG-100602 specifically block MRTF-A nuclear localization and thus inhibit the fibrogenic transcription factor SRF[1][2].
Related Catalog
In Vitro CCG-100602 (3-30 μM) decreases the number of adherent hASC cells[2]. CCG-100602 blocks the expression of MRTF-A/SRF-activated genes[2]. CCG-100602 (5-40 μM) diminishes the TGF-β1 (5 ng/mL)-induced increase in COL1A1, FN1, and ACTA2 transcription in a dose-dependent manner[1]. CCG-100602 (5-40 μM) reduces the TGF-β1-induced increase in MRTFA and SRF mRNA expression in the HIMFs in a dose-dependent manner [1]. CCG-100602 (5-40 μM) significantly reduces the protein expression levels of the ECM and α-SMA in TGF-β1 (5 ng/mL)-stimulated cells in a dose-dependent manner[1]. CCG-100602 (5-40 μM) also significantly represses the MRTF-A and SRF protein expression, which were induced by TGF-β1, in the nuclear fraction of the HIMFs in a dose-responsive manner[1]. Cell Viability Assay[2] Cell Line: Human adipose stem cell (hASC) Concentration: 3, 8, 15, or 30 μM Incubation Time: 7 days Result: The number of adherent cells decreased as a response to increasing inhibitor amount. The effect was also dependent on the culture media because the osteogenic medium condition supported the viability over basic culture medium and adipogenic medium conditions. RT-PCR[1] Cell Line: Human intestinal myofibroblasts (HIMFs) Concentration: 5, 10, 20, and 40 μM Incubation Time: 30 min prior to the addition of TGF-β1 (5 ng/mL) for 24 hours Result: Diminished the TGF-β1-induced increase in COL1A1, FN1, and ACTA2 transcription in a dose-dependent manner. Reduced the TGF-β1-induced increase in MRTFA and SRF mRNA expression in the HIMFs in a dose-dependent manner. Western Blot Analysis[1] Cell Line: Human intestinal myofibroblasts (HIMFs) Concentration: 5, 10, 20, and 40 μM Incubation Time: 30 min prior to the addition of TGF-β1 (5 ng/mL) for 48 hours Result: The protein expression levels of the ECM and α-SMA in TGF-β1-stimulated cells are significantly reduced. Repressed the MRTF-A and serum response factor (SRF) protein expression, which were induced by TGF-β1, in the nuclear fraction of the HIMFs.
In Vivo Treatment with CCG-100602 (7.5 mg/kg/day, continuously administered for 2 weeks by osmotic minipumps) abrogates the increase of aortic stiffness represented by reduced arterial compliance and strain, indicating a significant anti-stiffening effect resulting from the inhibition of SRF/myocardin[3]. Animal Model: Adult (4 month-old) male spontaneously hypertensive rats (SHR) and normotensive control Wistar-Kyoto (WKY) rats[3] Dosage: 7.5 mg/kg/day Administration: Continuously administered for 2 weeks by osmotic minipumps. Result: Abrogated the increase of aortic stiffness represented by reduced arterial compliance and strain.
References

[1]. Yoon Jeong Choi, et al. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A. Stem Cell Res Ther. 2019 Sep 23;10(1):291.

[2]. Laura Hyväri, et al. Myocardin-Related Transcription Factor A (MRTF-A) Regulates the Balance between Adipogenesis and Osteogenesis of Human Adipose Stem Cells. Stem Cells Int. 2020 Sep 22;2020:8853541.

[3]. Ning Zhou, et al. Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension. Cell Physiol Biochem. 2017;44(2):701-715.

Density 1.4±0.1 g/cm3
Boiling Point 563.8±50.0 °C at 760 mmHg
Molecular Formula C21H17ClF6N2O2
Molecular Weight 478.815
Flash Point 294.8±30.1 °C
Exact Mass 478.088287
PSA 49.41000
LogP 5.20
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.544
Hazard Codes Xi
Precursor  2

DownStream  0